Asset 2 Conferences
Mirjolet Jean François - profile picture

Jean-François Mirjolet

Technology Director Oncodesign, FR

Jean-François has joined Oncodesign in 2003 as a study director (the head of cellular pharmacology). Since his arrival at Oncodesign, he has played a central role in the development of tools to evaluate immune related therapies such as reconstituted human immune system mouse models (Chi-mice®). Jean-François obtained his Ph.D. from the University of Nancy, France, in cellular pharmacology of anticancer drugs, followed by post-doctoral position at the IRIBHM, Brussels, Belgium, in chemokines and chemokine receptors implication in cancer cell migration. He is now the Technology Director at Oncodesign, directly supporting our Business Development activity and working closely with our clients to select the most appropriate study designs for the evaluation of their therapies through preclinical studies.

Speaker at